Kondro, Wayne
October 2010
CMAJ: Canadian Medical Association Journal;10/19/2010, Vol. 182 Issue 15, pE717
Academic Journal
The article offers news briefs related to medical care. Alzheimer's Disease International estimated 604 billion U.S. dollar world wide cost of dementia in 2010. Forest Pharmaceuticals Inc. agreed to pay criminal penalties for distributing an unapproved drug and a misbranded drug and obstructing a Food and Drug Administration Investigation. Great Britain Health Minister Simon Burns announced government's plan of scrapping the 12 pound billion National Programme for information technology.


Related Articles

  • NEWS. Rikein Jr., Reginald; Selby, Philip; Levine, F.A.; Revenas, B.; Appleby, John; Delamothe, Tony; Boyton, Rosemary; Warden, John // BMJ: British Medical Journal (International Edition);1/6/90, Vol. 300 Issue 6716, p5 

    Reports developments on health services around the world as of January 1990. Reformation on United States Food and Drug Administration; Revisions on the International Classification of Diseases (ICD) in Geneva; Decentralization on health care in Sweden.

  • News. Kaye, Donald // Clinical Infectious Diseases;1/15/2003, Vol. 36 Issue 2, pi 

    Focuses on several news and developments related to medical care in the United States as of January 15, 2003. Development of early warning system against protection of biological attacks by the U.S. military; Final guidance document issues by the U.S. Food and Drug Administration (FDA) to blood...

  • Most Mobile Medical Apps Avoid Strict FDA Oversight.  // O&P Business News;Nov2013, Vol. 22 Issue 13, p30 

    The article reports that the U.S. Food and Drug Administration (FDA) will impose lesser regulations on mobile medical applications in the country with minimal risks.

  • Roflumilast: An oral agent for severe COPD. Tanzi, Maria G. // Pharmacy Today;Apr2011, Vol. 17 Issue 4, p34 

    The article reports on the approval of the oral drug Roflumilast from Forest Pharmaceutical Inc. by the U.S. Food and Drug Administration to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations. It notes that the drug's clinical trial program involved more than 9,000...

  • Sankyo & Forest hit with warning. S.M. // Medical Marketing & Media;Feb2006, Vol. 41 Issue 2, p12 

    The article reports that the U.S. Food and Drug Administration's division of Drug Marketing, Advertising and Communications has warned Sankyo and Forest for claims the companies made in sales materials for its Benicar franchise. The agency ordered the companies to stop circulating the material...

  • FDA Warns Antipsychotic Drugs May Be Risky for Elderly. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;5/25/2005, Vol. 293 Issue 20, p2462 

    Reports the U.S. Food and Drug Administration warned that antipsychotic drugs can increase the death rate in elderly dementia patients. Information from studies on olazapine, aripiprazole, risperidone, and quetiapine; Indication two other atypical antipsychotics approved by the FDA, clozapine...

  • Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians. Qaseem, Amir; Snow, Vincenza; Cross Jr., J. Thomas; Forciea, Mary Ann; Hopkins Jr., Robert; Shekelle, Paul; Adelman, Alan; Mehr, David; Schellhase, Kenneth; Campos-Outcalt, Doug; Santaguida, Pasqualina; Owens, Douglas K. // Annals of Internal Medicine;3/4/2008, Vol. 148 Issue 5, p370 

    Description: The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia. Methods: The targeted literature search included evidence related to the effectiveness of 5 U.S....

  • FDA to boost CMI initiatives after study shows voluntary system is ineffective.  // Drug Store News;1/19/2009, Vol. 31 Issue 1, p41 

    The article reports on the plan of the U.S. Food and Drug Administration (FDA) to enhance consumer medication information (CMI). FDA stresses that the move aims to meet the needs and demands of consumers concerning the provision of quality information on the use of medicines. It reveals that the...

  • FDA Continues to Promote Public Health in its Centennial Year.  // BioPharm International;Apr2007, Vol. 20 Issue 4, p16 

    The article focuses on the centennial celebration of the Food and Drug Administration (FDA) as a premier public health agency in the U.S. The FDA aims for the protection and promotion of public health and to accomplish its mission, three organizations under its line that regulate health care...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics